These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23840511)

  • 21. Phylogenetic Diversity in Core Region of Hepatitis C Virus Genotype 1a as a Factor Associated with Fibrosis Severity in HIV-1-Coinfected Patients.
    Parra M; Laufer N; Manrique JM; Jones LR; Quarleri J
    Biomed Res Int; 2017; 2017():1728456. PubMed ID: 29259976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impaired CD4⁺ T cell stimulation of NK cell anti-fibrotic activity may contribute to accelerated liver fibrosis progression in HIV/HCV patients.
    Glässner A; Eisenhardt M; Kokordelis P; Krämer B; Wolter F; Nischalke HD; Boesecke C; Sauerbruch T; Rockstroh JK; Spengler U; Nattermann J
    J Hepatol; 2013 Sep; 59(3):427-33. PubMed ID: 23665286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Host genetic factors influence disease progression in chronic hepatitis C.
    Powell EE; Edwards-Smith CJ; Hay JL; Clouston AD; Crawford DH; Shorthouse C; Purdie DM; Jonsson JR
    Hepatology; 2000 Apr; 31(4):828-33. PubMed ID: 10733535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of Inflammatory/Immune Response and Cytokine Polymorphisms in the Severity of Chronic Hepatitis C (CHC) before and after Direct Acting Antiviral (DAAs) Treatment.
    Ferreira J; Oliveira M; Bicho M; Serejo F
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High tumor necrosis factor-α/interleukin-10 ratio is associated with hepatocellular carcinoma in patients with chronic hepatitis C.
    Aroucha DC; do Carmo RF; Moura P; Silva JL; Vasconcelos LR; Cavalcanti MS; Muniz MT; Aroucha ML; Siqueira ER; Cahú GG; Pereira LM; Coêlho MR
    Cytokine; 2013 Jun; 62(3):421-5. PubMed ID: 23602201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TNF-α and IL-10 polymorphisms increase the risk to hepatocellular carcinoma in HCV infected individuals.
    Aroucha DC; Carmo RF; Vasconcelos LR; Lima RE; Mendonça TF; Arnez LE; Cavalcanti Mdo S; Muniz MT; Aroucha ML; Siqueira ER; Pereira LB; Moura P; Pereira LM; Coêlho MR
    J Med Virol; 2016 Sep; 88(9):1587-95. PubMed ID: 26890368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in HIV/hepatitis C virus-coinfected patients.
    Rallón NI; Naggie S; Benito JM; Medrano J; Restrepo C; Goldstein D; Shianna KV; Vispo E; Thompson A; McHutchison J; Soriano V
    AIDS; 2010 May; 24(8):F23-9. PubMed ID: 20389235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin 28B rs12979860 (CT/TT) genotype is associated with milder hepatic damage in the natural evolution of HCV/HIV coinfection.
    de la Fuente C; Hinojosa C; Gilabert I; Jiménez Sousa MÁ; González JM; Ortiz de Lejarazu R; Loma A; Nieto C; Arnaiz R; Bermejo-Martin JF
    J Interferon Cytokine Res; 2013 Jan; 33(1):43-7. PubMed ID: 23030669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Macrophage Activation and the Tumor Necrosis Factor Cascade in Hepatitis C Disease Progression Among HIV-Infected Women Participating in the Women's Interagency HIV Study.
    French AL; Martin JW; Evans CT; Peters M; Kessaye SG; Nowicki M; Kuniholm M; Golub E; Augenbraun M; Desai SN;
    J Acquir Immune Defic Syndr; 2017 Dec; 76(4):438-444. PubMed ID: 29077674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic variants upstream of TNFAIP3 in the 6q23 region are associated with liver disease severity in HIV/HCV-coinfected patients: A cross-sectional study.
    Jiménez-Sousa MA; Berenguer J; Fernández-Rodríguez A; Medrano LM; Aldámiz-Echevarria T; Pérez-Latorre L; Díez C; Martín-Vicente M; Gutiérrez-Rivas M; Martínez I; Resino S
    Infect Genet Evol; 2019 Jan; 67():112-120. PubMed ID: 30336268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor necrosis factor alpha promoter polymorphisms at position -308 in Taiwanese chronic hepatitis C patients treated with interferon-alpha.
    Yu ML; Dai CY; Chiu CC; Lee LP; Lin ZY; Chen SC; Hsieh MY; Wang LY; Chen CJ; Chuang WL; Chang WY
    Antiviral Res; 2003 Jun; 59(1):35-40. PubMed ID: 12834858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IL-10 and TNF-alpha polymorphisms and the recovery from HCV infection.
    Lio D; Caruso C; Di Stefano R; Colonna Romano G; Ferraro D; Scola L; Crivello A; Licata A; Valenza LM; Candore G; Craxì A; Almasio PL
    Hum Immunol; 2003 Jul; 64(7):674-80. PubMed ID: 12826369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Chronic hepatitis C in patients with HIV/HCV coinfection with high CD4+ lymphocytes count].
    Inglot M; Szymczak A; Gładysz A; Małyszczak K; Zalewska M
    Przegl Epidemiol; 2007; 61(3):535-43. PubMed ID: 18069391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single nucleotide polymorphisms of CXCL9-11 chemokines are associated with liver fibrosis in HIV/HCV-coinfected patients.
    Pineda-Tenor D; Berenguer J; García-Álvarez M; Guzmán-Fulgencio M; Carrero A; Aldámiz-Echevarria T; Tejerina F; Diez C; Jiménez-Sousa MA; Fernández-Rodríguez A; Munoz-Fernandez MA; Resino S
    J Acquir Immune Defic Syndr; 2015 Apr; 68(4):386-95. PubMed ID: 25559603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progression of chronic hepatitis C to liver fibrosis and cirrhosis in patients coinfected with hepatitis C virus and human immunodeficiency virus.
    Martinez-Sierra C; Arizcorreta A; Díaz F; Roldán R; Martín-Herrera L; Pérez-Guzmán E; Girón-González JA
    Clin Infect Dis; 2003 Feb; 36(4):491-8. PubMed ID: 12567308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver fibrosis progression in HIV/hepatitis C virus coinfected patients with normal aminotransferases levels.
    Pace FH; Ferreira LE; Silva AE; Ferraz ML
    Rev Soc Bras Med Trop; 2012; 45(4):444-7. PubMed ID: 22930041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCC.
    Fabris C; Falleti E; Cussigh A; Bitetto D; Fontanini E; Bignulin S; Cmet S; Fornasiere E; Fumolo E; Fangazio S; Cerutti A; Minisini R; Pirisi M; Toniutto P
    J Hepatol; 2011 Apr; 54(4):716-22. PubMed ID: 21146242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advanced liver fibrosis in HIV/HCV-coinfected patients on antiretroviral therapy.
    Fuster D; Planas R; Muga R; Ballesteros AL; Santos J; Tor J; Sirera G; Guardiola H; Salas A; Cabré E; Ojanguren I; Barluenga E; Rey-Joly C; Clotet B; Tural C
    AIDS Res Hum Retroviruses; 2004 Dec; 20(12):1293-7. PubMed ID: 15650421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular mechanisms of liver fibrosis in HIV/HCV coinfection.
    Mastroianni CM; Lichtner M; Mascia C; Zuccalà P; Vullo V
    Int J Mol Sci; 2014 May; 15(6):9184-208. PubMed ID: 24865485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin 10 responses are associated with sustained CD4 T-cell counts in treated HIV infection.
    Villacres MC; Kono N; Mack WJ; Nowicki MJ; Anastos K; Augenbraun M; Liu C; Landay A; Greenblatt RM; Gange SJ; Levine AM
    J Infect Dis; 2012 Sep; 206(5):780-9. PubMed ID: 22693231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.